Biotin anti-human GM-CSF Antibody anti-GM-CSF - BVD2-21C11,BioLegend,502304

Additional reported applications (for the relevant formats) include: ELISA1-4or ELISPOT3,4Detection, Neutralization1, immunohistochemical staining of paraformaldehyde-fixed, saponin-treated5,6and acetone-fixed7frozen tissue sections, and immunocytochemistry.Note:For testing human GM-CSF in serum or plasma, BioLegend's ELISA Max™ Sets (Cat. No. 432001 to 432006) are specially developed and recommended.

Host

Rat

Reactivity

Human

Application

ELISA Detection, ELISPOT Detection, ICFC

Platform ID

BAB399853709

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameBiotin anti-human GM-CSF Antibody anti-GM-CSF - BVD2-21C11
Cat. No.502304
HostRat
RRIDAB_315218 (BioLegend Cat. No. 502304)
IsotypeRat IgG2a, κ
ReactivityHuman
ApplicationELISA Detection, ELISPOT Detection, ICFC
ClonalityMonoclonal
Clone NumberBVD2-21C11
Concentration0.5 mg/ml
TargetGM-CSF
ImmunogenE. coli-expressed, recombinant human GM-CSF.
PurityThe antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

Granulocyte/macrophage - colony stimulating factor (GM-CSF) is a hematopoietic factor that is produced by activated T cells, B cells, mast cells, macrophages, fibroblasts, and endothelial cells. In addition to supporting colony formation of granulocyte/macrophage progenitors, GM-CSF is a growth factor for erythroid, megakaryocyte, and eosinophil progenitors.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.